Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

Abstract Background Endothelial progenitor cells (EPCs) has been shown to be dysfunctional in both type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) leading to poor regeneration of endothelium and renal perfusion. EPCs have been shown to be a robust cardiovascular disease (CVD) risk i...

Full description

Bibliographic Details
Main Authors: Seshagiri Rao Nandula, Nabanita Kundu, Hassan B. Awal, Beda Brichacek, Mona Fakhri, Nikhila Aimalla, Adrian Elzarki, Richard L. Amdur, Sabyasachi Sen
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Cardiovascular Diabetology
Subjects:
Canagliflozin
Type 2 diabetes
Progenitor cells
Endothelial function
Urinary exosomes
Online Access:https://doi.org/10.1186/s12933-021-01235-4

Internet

https://doi.org/10.1186/s12933-021-01235-4

Similar Items